Document is current

Any future updates will be listed below

Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors

Crossref DOI link: https://doi.org/10.1186/s13550-016-0229-0

Published Online: 2016-10-10

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark